Federal appeals panel asks skeptical questions about FDA approval of abortion drug

Contributing sentiments towards policy:

57% : A group of anti-abortion doctors called the Alliance for Hippocratic Medicine challenged the FDA's approval of the drug two decades ago, and several agency steps in 2016 that expanded access to it.
54% : Much of Wednesday's hearing at the U.S. Fifth Circuit Court of Appeals focused on whether a group of anti-abortion doctors has legal standing to challenge the FDA's approval in 2000 and subsequent expanded access for mifepristone, one of two drugs used commonly in chemical abortions.
43% : All three judges questioned the regulatory basis for the drug's approval and expanded access, while steering clear of a national debate over abortion itself, following the U.S. Supreme Court's ruling last June removing a constitutional right to the procedure.

*Our bias meter rating uses data science including sentiment analysis, machine learning and our proprietary algorithm for determining biases in news articles. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral. The rating is an independent analysis and is not affiliated nor sponsored by the news source or any other organization.